Arcutis Director Sells $121,000 Amid ZORYVE Revenue Surge
A biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
Find out which travel credit cards without fees provide the most rewarding experiences for your travels.
26,586 articlesA biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
Warren Buffett’s latest move at Berkshire Hathaway signals a rare, hands-on embrace of a mega-stock. This piece break...
A senior Pentagon official describes a turning point when DoD leaders realized their reliance on a single AI provider...
TONX reported healthy momentum in Q1 2026, but the real story lies in its growth engine. This article breaks down th...
A sudden drop in Navitas stock sent ripples through growth-focused portfolios. This guide explains the key drivers, w...
As AI reshapes manufacturing and logistics, the ROBO ETF is gaining attention for its diversified approach to robotic...
A fresh group of stocks tied to memory chips is redefining global markets as AI data centers push demand higher. The ...
Plug Power recently beat quarterly estimates, but that isn’t a guarantee the stock is safe to buy. This guide breaks ...
Could the better buy: taiwan semiconductor be the key to your next growth position? This guide weighs TSM and MU on s...
Investors targeting higher income are turning to closed-end funds trading at discounts to NAV, seeking a compelling y...
Oklo is combining AI with nuclear reactor design to shorten development timelines and improve safety. This article br...
An insider stake moved when a Freshworks executive sold over 32,577 shares for roughly $275,000. This article breaks ...